Trek Financial
XBI icon

Trek Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Trek Financial’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.7M Buy
80,717
+41,441
+106% +$6.54M 0.59% 43
2026
Q2 		$6.22M Buy
+39,276
New +$5.31M 0.31% 89
2024
Q2 		– Sell
-90,760
Closed -$8.61M – 471
2024
Q1 		$8.61M Buy
+90,760
New +$8.42M 0.68% 40

Other funds holding XBI

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return
Annex Advisory Services
Annex Advisory Services Brookfield, Wisconsin $6.11B AUM 13.75% 1-Year Est. Return
MIRAE ASSET SECURITIES (USA) INC.
MIRAE ASSET SECURITIES (USA) INC. New York $3.57B AUM 26.72% 1-Year Est. Return
Moss Adams Wealth Advisors
Moss Adams Wealth Advisors Seattle, Washington $1.53B AUM 19.03% 1-Year Est. Return
SGH
Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return
Parkway Wealth Management
Parkway Wealth Management Plano, Texas $869M AUM 25.74% 1-Year Est. Return
Weatherly Asset Management
Weatherly Asset Management Del Mar, California $1.42B AUM 33.31% 1-Year Est. Return
J. Safra Asset Management
J. Safra Asset Management New York $2.3B AUM 21.55% 1-Year Est. Return

Trek Financial's XBI Position: Q3 2026 in Review

Trek Financial increased its State Street SPDR S&P Biotech ETF (XBI) stake by 106% in Q3 2026, buying an estimated $6.54M and bringing the position to 80,717 shares worth $12.7M. The position accounts for 0.59% of the portfolio, ranked #43.

Trek Financial first reported a position in XBI in Q1 2024 and has held it in 3 quarters since. 437 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Trek Financial held 80,717 shares of State Street SPDR S&P Biotech ETF worth $12.7M as of Q3 2026.
  • Trek Financial bought 41,441 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $6.54M.
  • State Street SPDR S&P Biotech ETF made up 0.59% of Trek Financial's portfolio in Q3 2026, its #43 holding.
  • Trek Financial first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and has held it in 3 quarters since.
  • 437 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Trek Financial's 13F filing for Q3 2026, filed 29 Oct 2026.